Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Co-Diagnostics, Inc. (CODX : NSDQ)
 
 • Company Description   
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.

Number of Employees: 101

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.63 Daily Weekly Monthly
20 Day Moving Average: 264,273 shares
Shares Outstanding: 33.99 (millions)
Market Capitalization: $157.36 (millions)
Beta: -1.90
52 Week High: $11.82
52 Week Low: $3.66
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 3.81% 9.17%
12 Week -19.48% -11.23%
Year To Date -48.15% -37.89%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2401 S. FOOTHILL DRIVE SUITE D
-
SALT LAKE CITY,UT 84109
USA
ph: 801-438-1036
fax: -
investors@codiagnostics.com http://www.codiagnostics.com
 
 • General Corporate Information   
Officers
Dwight Egan - Chief Executive Officer; President and Director
Brian Brown - Chief Financial Officer
Eugene Durenard - Director
Edward Murphy - Director
James Nelson - Director

Peer Information
Co-Diagnostics, Inc. (CHCR)
Co-Diagnostics, Inc. (ESRX)
Co-Diagnostics, Inc. (MYDP)
Co-Diagnostics, Inc. (GBCS)
Co-Diagnostics, Inc. (LAXAF)
Co-Diagnostics, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 189763105
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 33.99
Most Recent Split Date: (:1)
Beta: -1.90
Market Capitalization: $157.36 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.14 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.67 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 6.91
Trailing 12 Months: 3.80
PEG Ratio: -
Price Ratios
Price/Book: 1.06
Price/Cash Flow: 3.62
Price / Sales: 1.56
EPS Growth
vs. Year Ago Period: 0.00%
vs. Previous Quarter: 4.00%
Sales Growth
vs. Year Ago Period: 13.35%
vs. Previous Quarter: 11.26%
ROE
03/31/22 - 32.20
12/31/21 - 36.83
09/30/21 - 50.81
ROA
03/31/22 - 28.57
12/31/21 - 33.38
09/30/21 - 47.89
Current Ratio
03/31/22 - 9.63
12/31/21 - 9.14
09/30/21 - 24.83
Quick Ratio
03/31/22 - 9.25
12/31/21 - 8.98
09/30/21 - 24.03
Operating Margin
03/31/22 - 37.59
12/31/21 - 37.45
09/30/21 - 40.11
Net Margin
03/31/22 - 40.25
12/31/21 - 37.45
09/30/21 - 40.11
Pre-Tax Margin
03/31/22 - 48.58
12/31/21 - 46.62
09/30/21 - 48.94
Book Value
03/31/22 - 4.35
12/31/21 - 4.65
09/30/21 - 3.47
Inventory Turnover
03/31/22 - 3.23
12/31/21 - 2.96
09/30/21 - 2.48
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©